Dr. Berzhanskaya is a Program Director for trans-NIH REACH 2.0 and Innovator Support Lead at the National Heart Lung and Blood Institute (NHLBI) Innovation& Commercialization Office. Previously, she served as a Scientific Review Officer and a Program Official at the National Institute on Drug Abuse (NIDA). There, she oversaw device/ big data/digital health portfolio, SBIR/STTR grants and contracts. Julia has contributed to several trans-NIH initiatives including HEAL, BRAIN, SPARC, MMM, NSF-NIH Smart and Connected Health and Digital Twin efforts.
NHLBI Innovation & Commercialization helps innovators in academia and industry translate new and promising discoveries into biomedical products that prevent, diagnose, and treat heart, lung, blood, and sleep diseases and disorders.
Julia Berzhanskaya
Program Director for trans-NIH REACH 2.0 and Innovator Support Lead
National Heart Lung and Blood Institute (NHLBI) Innovation& Commercialization Office